CLRB News and Press, Cellectar Biosciences Inc. From 01/27/21

FLORHAM PARK, N.J., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced that the European Medicin...

Cellectar Biosciences ([[CLRB]] +4.3%) has initiated a pivotal trial in the U.S., for CLR 131 in Waldenstrom’s macroglobulinemia ((WM)), a rare cancer of the bone marrow and lymphatic tissues.The pivotal trial is designed as a global, non-comparator, single arm, expansion cohort of the...

FLORHAM PARK, N.J., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced the initiation of a pivot...

Insiders Made These Their Top Penny Stocks To Buy Before The New Year Whether we’re talking about penny stocks or blue-chip stocks, insider transactions are always something of interest for traders. Playing more to the psychology of day trading or investing, when insiders...

FLORHAM PARK, N.J., Dec. 28, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced the closing of its previously a...

Biotech Penny Stocks To Watch With Recent Updates It’s funny to think that 2020 is almost over yet penny stocks remain a major focus for traders right now. One of the main reasons for this has been the unrelenting focus on volatility. Believe it or not, I think 2020 was p...

Gainers: Jaguar Health (JAGX) +191%.Ocugen (OCGN) +177%.Acasti Pharma (ACST) +88%.Scopus BioPharma (SCPS) +50%.Foresight Autonomous Holdings (FRSX) +35%.Onconova Therapeutics (ONTX) +32%.Evogene (EVGN) +31%.Energous Corporation (WATT) +29%.VivoPower International (VVPR) +26%.Phoenix New Media...

Gainers: Ocugen (OCGN) +263%, Jaguar Health (JAGX) +108%, Acasti Pharma (ACST) +61%, Scopus BioPharma (SCPS) +43%, Ekso Bionics Holdings (EKSO) +21%.Losers: Cellectar Biosciences (CLRB) -31%, CRH Medical (CRHM) -23%, CNS Pharmaceuticals (...

Cellectar Biosciences (CLRB) prices previously announced underwritten public offering of its common stock for gross proceeds of ~$24.5M at a public offering price of $1.35 per share.In a separate concurrent private placement transaction led by healthcare-focused institutional investors, compa...

FLORHAM PARK, N.J., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced the pricing of its previously a...